RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 41.66

Change

0.00 (0.00)%

Market Cap

N/A

Volume

8.70K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-20 )

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

N/A

USD 0.10B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

N/A

USD 9.26B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

N/A

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.21B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

N/A

N/A
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.29% 67% D+ 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.29% 67% D+ 48% F
Trailing 12 Months  
Capital Gain -10.62% 43% F 24% F
Dividend Return 1.29% 77% C+ 26% F
Total Return -9.33% 43% F 23% F
Trailing 5 Years  
Capital Gain 54.34% 40% F 57% F
Dividend Return 4.68% 27% F 9% A-
Total Return 59.02% 37% F 48% F
Average Annual (5 Year Horizon)  
Capital Gain 8.36% 29% F 64% D
Dividend Return 8.74% 28% F 59% D-
Total Return 0.39% 23% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 29.03% 97% N/A 34% F
Risk Adjusted Return 30.12% 50% F 46% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.